← Leaderboards
Walter Nmn Ling
University Of California Los Angeles
$59,224,910
Attributed
$59,224,910
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $5.6M · FY2005–15$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$59,224,910 · 8
By mechanism
U10$52,595,825 · 1
R01$5,998,146 · 3
M01$630,939 · 4
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Robert S Kern$2,226,800
- Lara Ray$13,872,420
- Yih-Ing Hser$23,860,625
- Rajkumar Jyotishchandra Sevak$206,683
- Honghu Liu$13,885,435
Others in their field
Top investigators on “Behavior Therapy”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Lawrence Corey · Fred Hutchinson Cancer Center$266,084,164
- Sharon A Nachman · Johns Hopkins University$193,704,208
- Constance Ann Benson · University Of California, San Diego$167,301,325
- Judith S. Currier · University Of California Los Angeles$157,727,855
Research focus
Behavior TherapyTrainingBuprenorphinePharmaceutical PreparationsClinical ResearchParticipantProtocols DocumentationBaseMethadoneResearch PersonnelFundingDoctor Of MedicineSubstance Abuse ProblemNational Institute Of Drug AbuseProgramsAddictionCountryCommunitiesManualsHealth PersonnelModalityNamed GroupClinical Trials NetworkDrug Abuse
Grant awards (65)
The National Drug Abuse Treatment Clinical Trials Network$2,953,306
U10 · FY2015 · DA · contact PI
The National Drug Abuse Treatment Clinical Trials Network$2,614,624
U10 · FY2014 · DA · contact PI
The National Drug Abuse Treatment Clinical Trials Network$1,711,946
U10 · FY2014 · DA · contact PI
The National Drug Abuse Treatment Clinical Trials Network$1,729,183
U10 · FY2013 · DA · contact PI
The National Drug Abuse Treatment Clinical Trials Network$1,537,275
U10 · FY2013 · DA · contact PI
The National Drug Abuse Treatment Clinical Trials Network$801,555
U10 · FY2013 · DA · contact PI
The National Drug Abuse Treatment Clinical Trials Network$1,641,749
U10 · FY2012 · DA · contact PI
The National Drug Abuse Treatment Clinical Trials Network$1,172,018
U10 · FY2012 · DA · contact PI
The National Drug Abuse Treatment Clinical Trials Network$562,466
U10 · FY2012 · DA · contact PI
Sustained-Release Methylphenidate For Management of Methamphetamine Use Disorders$456,056
R01 · FY2012 · DA · contact PI
The National Drug Abuse Treatment Clinical Trials Network$433,383
U10 · FY2012 · DA · contact PI
The National Drug Abuse Treatment Clinical Trials Network$427,086
U10 · FY2012 · DA · contact PI
The National Drug Abuse Treatment Clinical Trials Network$74,176
U10 · FY2012 · DA · contact PI
The National Drug Abuse Treatment Clinical Trials Network$1,180,255
U10 · FY2011 · DA · contact PI
The National Drug Abuse Treatment Clinical Trials Network$736,265
U10 · FY2011 · DA · contact PI
The National Drug Abuse Treatment Clinical Trials Network$620,499
U10 · FY2011 · DA · contact PI
The National Drug Abuse Treatment Clinical Trials Network$497,172
U10 · FY2011 · DA · contact PI
Sustained-Release Methylphenidate For Management of Methamphetamine Use Disorders$461,958
R01 · FY2011 · DA · contact PI
The National Drug Abuse Treatment Clinical Trials Network$943,255
U10 · FY2010 · DA · contact PI
National Drug Abuse Treatment Clinical Trials Network$745,343
U10 · FY2010 · DA · contact PI
The National Drug Abuse Treatment Clinical Trials Network$680,000
U10 · FY2010 · DA · contact PI
Optimizing Outcomes Using Suboxone for Opiate Dependence$490,347
R01 · FY2010 · DA · contact PI
Sustained-Release Methylphenidate For Management of Methamphetamine Use Disorders$467,090
R01 · FY2010 · DA · contact PI
The National Drug Abuse Treatment Clinical Trials Network$256,500
U10 · FY2010 · DA · contact PI
National Drug Abuse Treatment Clinical Trials Network$2,267,457
U10 · FY2009 · DA · contact PI
National Drug Abuse Treatment Clinical Trials Network$1,250,000
U10 · FY2009 · DA · contact PI
Optimizing Outcomes Using Suboxone for Opiate Dependence$490,818
R01 · FY2009 · DA · contact PI
Sustained-Release Methylphenidate For Management of Methamphetamine Use Disorders$446,931
R01 · FY2009 · DA · contact PI
National Drug Abuse Treatment Clinical Trials Network$285,323
U10 · FY2009 · DA · contact PI
National Drug Abuse Treatment Clinical Trials Network$104,545
U10 · FY2009 · DA · contact PI
National Drug Abuse Treatment Clinical Trials Network$99,868
U10 · FY2009 · DA · contact PI
National Drug Abuse Treatment Clinical Trials Network$1,327,000
U10 · FY2008 · DA · contact PI
National Drug Abuse Treatment Clinical Trials Network$1,250,000
U10 · FY2008 · DA · contact PI
Optimizing Outcomes Using Suboxone for Opiate Dependence$490,395
R01 · FY2008 · DA · contact PI
National Drug Abuse Treatment Clinical Trials Network$397,904
U10 · FY2008 · DA · contact PI
National Drug Abuse Treatment Clinical Trials Network$1,250,000
U10 · FY2007 · DA · contact PI
Optimizing Outcomes Using Suboxone for Opiate Dependence$489,949
R01 · FY2007 · DA · contact PI
National Drug Abuse Treatment Clinical Trials Network$331,589
U10 · FY2007 · DA · contact PI
National Drug Abuse Treatment Clinical Trials Network$3,803,000
U10 · FY2006 · DA · contact PI
National Drug Abuse Treatment Clinical Trials Network$1,250,000
U10 · FY2006 · DA · contact PI
Optimizing Outcomes Using Suboxone for Opiate Dependence (R01 DA 020210-01)$517,719
R01 · FY2006 · DA · contact PI
EFFECTS OF METHAMPHETAMINE ABUSE ON CEREVRAL GLUCOSE METABOLISM$3,603
M01 · FY2006 · RR · contact PI
National Drug Abuse Treatment Clinical Trials Network$3,640,000
U10 · FY2005 · DA
National Drug Abuse Treatment Clinical Trials Network$1,200,000
U10 · FY2005 · DA
NIDA CLINICAL TRIALS NETWORK: UCLA RESEARCH NODE$785,541
U10 · FY2005 · DA
EFFECTS OF METHAMPHETAMINE ABUSE ON CEREVRAL GLUCOSE METABOLISM$1,732
M01 · FY2005 · RR
NIDA CLINICAL TRIALS NETWORK: UCLA RESEARCH NODE$1,500,000
U10 · FY2004 · DA
NIDA CLINICAL TRIALS NETWORK: UCLA RESEARCH NODE$385,542
U10 · FY2004 · DA
NIDA CLINICAL TRIALS NETWORK: UCLA RESEARCH NODE$1,500,000
U10 · FY2003 · DA
NIDA CLINICAL TRIALS NETWORK: UCLA RESEARCH NODE$850,000
U10 · FY2003 · DA
PAIN ANALGESIC RESPONSE IN OPIATE DEPENDENCE$503,402
R01 · FY2003 · DA
PAIN ANALGESIC RESPONSE IN OPIATE DEPENDENCE$95,280
R01 · FY2003 · DA
NIDA CLINICAL TRIALS NETWORK: UCLA RESEARCH NODE$1,800,000
U10 · FY2002 · DA
NIDA CLINICAL TRIALS NETWORK: UCLA RESEARCH NODE$650,000
U10 · FY2002 · DA
PAIN ANALGESIC RESPONSE IN OPIATE DEPENDENCE$530,424
R01 · FY2002 · DA
NIDA CLINICAL TRIALS NETWORK: UCLA RESEARCH NODE$300,000
U10 · FY2002 · DA
NIDA CLINICAL TRIALS NETWORK: UCLA RESEARCH NODE$2,200,000
U10 · FY2001 · DA
NIDA CLINICAL TRIALS NETWORK: UCLA RESEARCH NODE$650,000
U10 · FY2001 · DA
PAIN ANALGESIC RESPONSE IN OPIATE DEPENDENCE$557,777
R01 · FY2001 · DA
PHARMACOKINETICS AND BIOAVAILABILITY OF LIQUID VS. TABLET BUPRENORPHINE$207,266
M01 · FY2001 · RR
SAFETY EVALUATION OF LOFEXIDINE FOR THE TREATMENT OF OPIATE WITHDRAWAL$207,266
M01 · FY2001 · RR
NIDA CLINICAL TRIALS NETWORK: UCLA RESEARCH NODE$2,200,000
U10 · FY2000 · DA
SAFETY EVALUATION OF LOFEXIDINE FOR THE TREATMENT OF OPIATE WITHDRAWAL$207,266
M01 · FY2000 · RR
SAFETY EVALUATION OF LOFEXIDINE FOR THE TREATMENT OF OPIATE WITHDRAWAL$1,903
M01 · FY2000 · RR
PHARMACOKINETICS AND BIOAVAILABILITY OF LIQUID VS. TABLET BUPRENORPHINE$1,903
M01 · FY2000 · RR